Other official information and services: www.belgium.be  belgium

Dopaminergic agents (anti-parkinson drug)

Key figures

PRESCRIBERS
Main prescribers: General practitioners 59.47%
INSURED CONSUMERS
% of insured consumers 0.70%
Median age 75 years
Max/min ratio of the median age (by district) 1.08
Percentage of women 55.04%
Ratio Preferential scheme/General scheme 1.50
Coefficient of variation (2023) 16.14
Max/min ratio of % of insured consumers (by district) 2.22
CONSUMPTION
Annual consumption (DDD) 18,911,765
Consumption of DDD (per 100,000 insured persons) 164,157.43
% DDD issued outside the insurance (approximate) 2.82%
Average annual consumption per insured consumer (DDD) 234.67
% of insured consumers with > 3 times the average consumption 8,85%
Coefficient of variation 2013-2015 17.30
Coefficient of variation 2021-2023 16.80
Trend 2013-2023 0.21%
Trend 2013-2021 0.35%
Trend 2021-2023 -0.36%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance 22,027,507 €
Average annual expenditure per insured person 1.91 €
Average patient share per insured consumer 17.00%
Max/min ratio of expenditure per insured person (by disctrict) 1.85
% “Low-cost” medication 89.18%
Trend 2013-2023 -3.36%
Trend 2021-2023 -0.12%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on a yellow background, otherwise on a grey background.

Download the full report

Download the methodology